We are live on ! Find out more
BCA

Burren Capital Advisors Portfolio holdings

AUM $33M
1-Year Est. Return 47.67%
This Fund
S&P 500
This Quarter Est. Return
-5.79%
1 Year Est. Return
+47.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$418K
AUM Growth
-$7.62M
Cap. Flow
-$7.61M
Cap. Flow %
-1,819.47%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$247K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$5.33M
2
FIT
Fitbit, Inc. Class A common stock
FIT
+$2.52M

Sector Composition

Rank Sector Weight
1 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY.RT
1
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$418K 100%
116,684
+68,354
+141% +$247K
FIT
2
DELISTED
Fitbit, Inc. Class A common stock
FIT
– –
-378,087
Closed -$2.52M
AGN
3
DELISTED
Allergan plc
AGN
– –
-30,117
Closed -$5.33M

Similar funds

VM
Valinor Management New York $32.2M AUM 44.16% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
AECF
Annie E. Casey Foundation Baltimore, Maryland $35.2M AUM 35.05% 1-Year Est. Return
PI
Pelion Inc Salt Lake City, Utah $36.3M AUM 3.33% 1-Year Est. Return
HCM
HGI Capital Management New York $36.4M AUM 4.49% 1-Year Est. Return
OC
ORIX Corp Tokyo, Japan $36.6M AUM 25.1% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
AM
Arkhouse Management New York $36.7M AUM

Burren Capital Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Burren Capital Advisors held 3 positions worth $418K, down 95% from $8.04M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Burren Capital Advisors withdrew a net $7.61M in Q2 2020, closing 2 positions. Its most notable exit was Allergan plc, an estimated $5.33M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 0% of assets, down from 66% a quarter earlier.

Against the trend, Burren Capital Advisors added an estimated $247K to Bristol-Myers Squibb Company Contingent Value Rights.

  • Burren Capital Advisors added most to Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020, an estimated $247K increase.
  • Burren Capital Advisors fully exited Allergan plc in Q2 2020, selling an estimated $5.33M.
  • Burren Capital Advisors's ten largest holdings make up 100% of its $418K portfolio in Q2 2020.
  • Burren Capital Advisors opened 0 new positions and closed 2 in Q2 2020.
  • Burren Capital Advisors's portfolio value fell 95% quarter-over-quarter to $418K.

Based on Burren Capital Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.